These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10577096)

  • 21. [MPTP parkinsonism].
    Kondo T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):37-40. PubMed ID: 10434585
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pesticide exposure and Parkinson's syndrome - the epidemiological and experimental evidence].
    Vieregge P
    Nervenarzt; 2002 Oct; 73(10):982-9. PubMed ID: 12376887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
    Feldman N; Croquette-Krokar M
    Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
    Natale G; Kastsiuchenka O; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():345-9. PubMed ID: 18991880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alessandro Agnoli Lecture. Models of basal ganglia dysfunction: predictions and pitfalls.
    Albin RL; Kearney JA
    Funct Neurol; 2000; 15(3):135-46. PubMed ID: 11062842
    [No Abstract]   [Full Text] [Related]  

  • 28. Ecstasy use-Parkinson's disease link tenuous.
    Jerome L; Doblin R; Mithoefer M
    Mov Disord; 2004 Nov; 19(11):1386. PubMed ID: 15389978
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 30. MDMA and Parkinsonism.
    Kuniyoshi SM; Jankovic J
    N Engl J Med; 2003 Jul; 349(1):96-7. PubMed ID: 12840102
    [No Abstract]   [Full Text] [Related]  

  • 31. A brief overview of the clinical pharmacology of "club drugs".
    Britt GC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The new drugs: ecstasy, GHB. Update for practitioners].
    Feldman N; Croquette-Krokar M
    Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyponatraemic coma after ecstasy ingestion.
    Nuvials X; Masclans JR; Peracaula R; de Latorre FJ
    Intensive Care Med; 1997 Apr; 23(4):480. PubMed ID: 9142593
    [No Abstract]   [Full Text] [Related]  

  • 34. [Toxicity of ecstasy].
    Mas M; Farré M; Roset PN; Camí J
    Med Clin (Barc); 1998 Oct; 111(13):516-7. PubMed ID: 9859071
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. 1990.
    Boyce S; Rupniak NM; Steventon MJ; Iversen SD
    Neurology; 2001 Nov; 57(10 Suppl 3):S27-33. PubMed ID: 11775597
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives.
    Guridi J; Obeso JA
    Adv Neurol; 1997; 74():235-47. PubMed ID: 9348418
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ecstasy: a falsely safe drug].
    Avila de Tomás JF
    Med Clin (Barc); 1998 Feb; 110(4):156. PubMed ID: 9541908
    [No Abstract]   [Full Text] [Related]  

  • 38. The agony and the ecstasy: acute urinary retention after MDMA abuse.
    Inman DS; Greene D
    BJU Int; 2003 Jan; 91(1):123. PubMed ID: 12614266
    [No Abstract]   [Full Text] [Related]  

  • 39. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Street narcotics].
    Kaa E; Müller IB; Rollmann D
    Ugeskr Laeger; 2003 Sep; 165(38):3633-4. PubMed ID: 14556400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.